VSee Health, Inc.
VSEE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4 | $3 | $3 | $4 |
| % Growth | 17.4% | 2.1% | -13.9% | – |
| Cost of Goods Sold | $2 | $2 | $1 | $1 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 52.1% | 46.9% | 56% | 63% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $4 | $3 | $4 |
| SG&A Expenses | $4 | $4 | $3 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2 |
| Other Operating Expenses | $0 | $0 | $1 | $1 |
| Operating Expenses | $4 | $4 | $4 | $6 |
| Operating Income | -$2 | -$2 | -$2 | -$4 |
| % Margin | -51.7% | -66.5% | -55.1% | -102.1% |
| Other Income/Exp. Net | $2 | -$0 | -$2 | -$1 |
| Pre-Tax Income | -$0 | -$3 | -$4 | -$4 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$0 | -$3 | -$4 | -$6 |
| % Margin | -7.3% | -77.1% | -119.2% | -145.6% |
| EPS | -0.02 | -0.16 | -0.24 | -0.36 |
| % Growth | 87.5% | 33.3% | 33.3% | – |
| EPS Diluted | -0.02 | -0.16 | -0.24 | -0.36 |
| Weighted Avg Shares Out | 17 | 16 | 16 | 16 |
| Weighted Avg Shares Out Dil | 17 | 16 | 16 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $1 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $1 | -$2 | -$3 | -$2 |
| % Margin | 28.5% | -50.1% | -76.7% | -63.2% |